ubmslateCN-logo-ubm

CN Mobile Logo

Search form

Topics:

Caroline Robert, MD, PhD

Caroline Robert, MD, PhD

Posts by Author

In this video we discuss 3-year results of the COMBI-d trial, which studied dabrafenib and trametinib in patients with unresectable or metastatic BRAF-mutated melanoma.

In this video we discuss 3-year overall survival data from the KEYNOTE-001 trial, which studied the anti–PD-1 antibody pembrolizumab in patients with advanced melanoma.

By clicking Accept, you agree to become a member of the UBM Medica Community.